Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

CORRECT: Fastnet In Talks For Reverse Takeover Of Amryt Pharma (ALLISS)

Mon, 22nd Feb 2016 10:33

(Correcting that Amryt Pharmaceuticals is based in Ireland.)

LONDON (Alliance News) - Fastnet Equity PLC shares were suspended on Monday after the company said it was holding advanced talks on a reverse takeover.

Fastnet said it is in advanced discussions with Ireland-based Amryt Pharmaceuticals DAC for a deal which would constitute a reverse takeover and see Fastnet focused on late-stage, specialty biopharmaceuticals.

As the deal would be a reverse takeover, Fastnet has requested its shares be suspended from trading pending publication of an admission document detailing the proposed deal.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

Related Shares

More News
11 Apr 2016 15:04

AGM, EGM Calendar - Week Ahead

31 Mar 2016 09:33

WINNERS & LOSERS SUMMARY: AO World Surges On Strong Fourth Quarter

31 Mar 2016 09:21

Orphan drug specialist Amryt Pharma to reverse into AIM's Fastnet

(ShareCast News) - Headed by Shire founder Harry Stratford as its chairman, speciality drug company Amryt Pharmaceuticals has confirmed its plan to re...

31 Mar 2016 07:41

Fastnet Equity To Become Amryt Pharma After Reverse Takeover (ALLISS)

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.